Recurrent promoter mutations in melanoma are defined by an extended context-specific mutational signature
Year: 2017
Type: article
Abstract: Sequencing of whole tumor genomes holds the promise of revealing functional somatic regulatory mutations, such as those described in the TERT promoter. Recurrent promoter mutations have been identified in many additional genes and appear to be particularly common in melanoma, but convincing functional data such as influence on gene expression has been more elusive. Here, we show that frequently recurring promoter mutations in melanoma occur almost exclusively at cytosines flanked by a distinct sequence signature, TTCCG, with TERT as a notable exception. In active, but not inactive, promoters, mutation frequencies for cytosines at the 5' end of this ETS-like motif were considerably higher than expected based on a UV trinucleotide mutational signature. Additional analyses solidify this pattern as an extended context-specific mutational signature that mediates an exceptional position-specific vulnerability to UV mutagenesis, arguing against positive selection. We further use ultra-sensitive amplicon sequencing to demonstrate that cell cultures exposed to UV light quickly develop subclonal mutations specifically in affected positions. Our findings have implications for the interpretation of somatic mutations in regulatory regions, and underscore the importance of genomic context and extended sequence patterns to accurately describe mutational signatures in cancer.
Source: PLoS Genetics
Institution: University of Gothenburg
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,048
Funders: Åke Wiberg Stiftelse, Stiftelsen för Strategisk Forskning, Cancerfonden, Knut och Alice Wallenbergs Stiftelse, Lars Erik Lundbergs Stiftelse för Forskning och Utbildning, Vetenskapsrådet, Barncancerfonden, Medical Research Council, Sahlgrenska Akademin, Uppsala Multidisciplinary Center for Advanced Computational Science, Wallenberg Centre for Molecular and Translational Medicine, National Human Genome Research Institute, National Cancer Institute
OpenAlex ID: W2952020316
